Teva Pharmaceutical Industries Newsroom

BofA Securities Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Raises Target Price to $26

Futu NewsJan 13 20:31 · Ratings

Klinge Biopharma Signs License Deal for Formycon's Eylea Biosimilar

MT NewswiresJan 13 15:20

Teva Announces Collaboration to Commercialize Formycon's Biosimilar Candidate to Eylea (Aflibercept) in Major Parts of Europe and in Israel

GlobeNewswireJan 13 14:00

FDA Says Teva Pharmaceuticals USA's Ethinyl Estradiol; Norethindrone Tablet, Chewable Has Been Discontinued

BenzingaJan 11 00:56

Samsung Bioepis and Teva Enter Into a Strategic Partnership for Commercialization of EPYSQLI (Eculizumab-aagh) in the United States

GlobeNewswireJan 10 21:30

Pharma Companies Welcome New Year With 583 Drug Price Hikes so Far

Seeking AlphaJan 10 04:36

Sector Update: Health Care Stocks Advance Late Afternoon

MT NewswiresJan 9 05:06

Catalyst Pharmaceuticals Jumps 14% on Firdapse Settlement With Teva

WSJJan 9 02:18

Catalyst Pharmaceuticals Announces Settlement Of FIRDAPSE Patent Litigation With Teva Pharmaceuticals; Teva Will Not Market Its Generic Version Of FIRDAPSE In The U.S. Any Earlier Than February 25, 2035, If Approved By The FDA

BenzingaJan 9 01:32

Express News | Catalyst Pharmaceuticals Inc - Penging Firdapse Patent Litigation Against Hetero and Lupin Ongoing

BreakingsJan 9 01:32

Teva Pharmaceuticals USA's Ezetimibe And Simvastatin, Tablet, 10 Mg; 10 Mg, 10 Mg; 20 Mg, 10 Mg; 20 Mg Discontinued

BenzingaJan 7 05:04

Express News | Teva : BofA Global Research Raises Price Objective to $26 From $25

BreakingsJan 6 21:40

Novo Nordisk Pushes FDA To Exclude Compounding For Its Early-Generation Diabetes Drug

BenzingaJan 6 21:00

Novo Nordisk Seeks to Block Compounded Victoza

Seeking AlphaJan 4 07:54

Insider Trades: Walmart, Teva Among Notable Names This Week

Seeking AlphaDec 29, 2024 00:03

Teva Pharmaceutical Industries Ltd (TEVA) Ends Trading Week Defying Market Bloodbath

Yahoo FinanceDec 28, 2024 22:27

Teva Pharmaceutical Industries(TEVA.US) Director Sells US$6.29 Million in Common Stock

$Teva Pharmaceutical Industries(TEVA.US)$ Director MIGNONE ROBERTO sold 286K shares of common stock on Dec 20, 2024 at an average price of $22.0071 for a total value of $6.29 million.Source:

Futu NewsDec 27, 2024 05:09

Teva Pharmaceutical Industries Insider Sold Shares Worth $6,294,031, According to a Recent SEC Filing

MT NewswiresDec 27, 2024 05:08

Teva Pharmaceutical on Track for Highest Close Since November 2018 -- Data Talk

Dow JonesDec 27, 2024 00:18

TEVA Stock Soars to 52-week High, Reaches $22.52

InvestingDec 26, 2024 23:26